Intermittent intravenous ibandronate therapy for osteoporosis

The author consecutively considers the introduction of intermittent use of ibandronate (I), by determining its single dose and annual cumulative dose. She presents data on the adequate antiresorptive activity of intermittent treatment, shows it necessary to design an intravenous dosage form of the d...

Full description

Bibliographic Details
Main Authors: L I Alekseeva, L I Alekseyeva
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2008-09-01
Series:Современная ревматология
Online Access:https://mrj.ima-press.net/mrj/article/view/175